期刊
JOURNAL OF NEUROCHEMISTRY
卷 136, 期 -, 页码 29-38出版社
WILEY
DOI: 10.1111/jnc.13217
关键词
IL-1 beta; inflammasome; neurodegenerative diseases
资金
- National Multiple Sclerosis Society (NMSS) [RG-1785G9-2, CA-1068-A-10]
- NIH [R37-AI029564]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029564] Funding Source: NIH RePORTER
The inflammasome is a large macromolecular complex that contains multiple copies of a receptor or sensor of pathogen-derived or damage-derived molecular patterns, pro-caspase-1, and an adaptor called ASC (apoptotic speck containing protein with a CARD), which results in caspase-1 maturation. Caspase-1 then mediates the release of pro-inflammatory cytokines such as IL-1 and IL-18. These cytokines play critical roles in mediating immune responses during inflammation and innate immunity. Broader studies of the inflammasome over the years have implicated their roles in the pathogenesis of a variety of inflammatory diseases. Recently, studies have shown that the inflammasome modulates neuroinflammatory cells and the initial stages of neuroinflammation. A secondary cascade of events associated with neuroinflammation (such as oxidative stress) has been shown to activate the inflammasome, making the inflammasome a promising therapeutic target in the modulation of neurodegenerative diseases. This review will focus on the pathogenic role that inflammasomes play in neurologic diseases such as Alzheimer's disease, traumatic brain injury, and multiple sclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据